Latest Share Chat

ABC.L Share News (ABC)

ABC.L Information

There is currently no data for ABC

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Mon, 02nd Aug 2021 08:55

(Alliance News) - Abcam PLC on Monday said it acquired BioVision, a wholly-owned subsidiary of Boai NKY Medical Holdings Ltd, for USD340 million.

Cambridge, England-based Abcam is a life science research firm. BioVision is a distributor of life science research tools to biopharma, diagnostic and academic customers.

The acquisition accelerates Abcam's strategic focus in the market for products in the complementary biochemical and cell-based assay market. It also will create value through portfolio expansion and leverage Abcam's global channels to market, the firm said.

The acquisition is expected to be accretive to adjusted earnings per share from the first full year of ownership.

"This acquisition represents a compelling opportunity to secure a proven portfolio of high-quality products, including a leading portfolio of biochemical and cell-based assay kits, that will allow us to better serve customer needs," said Chief Executive Alan Hirzel.

Shares in Abcam were up 0.9% to 1,370.00 pence each in London on Monday morning.

By Amrit Sahota; newsroom@alliancenews.com

More News

15 Jul 2010 08:09

Abcam: Earnings To Beat Views By 9% On Weak Pound, Savings

LONDON (Dow Jones)--Online antibody seller Abcam PLC (ABC.LN) Thursday said fiscal-year earnings will be about 9% ahead of average market expectations as a weak pound and cost savings boosted sales and profit. Abcam, which sells antibodies to researchers worldwide through an online catalogue of

15 Jul 2010 08:03

Weak pound helps Abcam profits

Abcam, which markets antibodies via its own online catalogue, said profit before tax will be around 9% higher than expectations as sales rose on the back of a weaker pound. The group said sterling has been weaker than in the first half of the year and this boosted sales more than was expected. "Du

23 Jun 2010 14:28

UK MARKET TALK ROUNDUP: BROKERS COMMENTS

Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markettalk.eu@dowjones.com 1328 GMT [Dow Jones] KBC Peel Hunt raises Abcam (ABC.LN) price target to 1400p from 1320p. It expects a positive FY'10 statem

23 Jun 2010 14:28

MARKET TALK: KBC Peel Hunt Raises Abcam Price Target

1328 GMT [Dow Jones] KBC Peel Hunt raises Abcam (ABC.LN) price target to 1400p from 1320p. It expects a positive FY'10 statement in July, based on strong current trading. Despite Abcam selling premium-priced products, KBC stills find its Amazon-like online platform the best on the market. "The compa

5 May 2010 16:43

May buys Begbies in May

Non-executive director John May has acquired his first shares in corporate recovery firm Begbies Traynor since joining the board in October 2007. May has bought 62,500 shares at 79p each, which cost just over £49,000. This follows yesterday's announcement that Begbies has obtained enlarged credi

27 Apr 2010 16:56

Abcam co-founder sells shares

Professor Tony Kouzarides, a co-founder of online catalogue-based antibodies distributor Abcam, has sold more than one-quarter of his shareholding. Professor Kouzarides sold 29,000 shares at 1187p each. That is just below the all time high of 1259p a share. He is left with 85,244 shares. Abcam fl

14 Mar 2010 11:02

Sunday tips round-up: BP, Kenmare Resources, Abcam

As one analyst said last week, "at last BP has bought a ticket to the carnival". The carnival he was referring to was, of course Brazilian oil. Most oil majors have a presence in the deep-water prospects in the area - with BP conspicuous by its absence. The group's shares are trading on a December

9 Mar 2010 14:51

Abcam profits surge

The second half of 2009 was a period of expansion for catalogue-based antibodies distributor Abcam wich increased the size of its catalogue, boosted its sales and craked up its profits. Sales in the six months to 31 December jumped 37.8% to £31.8m from £23.1m the year before, or by 25.3% on a cons

3 Nov 2009 16:18

Croda chief doubles his money

Croda International chief executive Michael Humphrey has taken up 109,300 shares via the senior executive option scheme and then sold most of them at nearly three times the price. The options were exercised at 256p a share, so the total cost was £280,000. The sale of 80,473 shares at 747.71p each

8 Sep 2009 17:01

London close: Footsie clings on to gains

Leading London shares closed mixed, with strong gains on resource stocks counter-balanced by losses on life assurance stocks. Kazakhmys, Antofagasta, Rio Tinto, Xstrata and Vedanta Resources led the mining sector higher, as metal prices improved. Gold miners Fresnillo and Randgold Resources were

8 Sep 2009 13:56

London afternoon: Holiday stocks take flight

After opening brightly London's leading shares have been treading water since the middle of the morning. Kazakhmys, Antofagasta, Rio Tinto, Xstrata and Vedanta Resources lead the mining sector higher, as metal prices improve. Gold miner Randgold Resources is wanted after the price of gold bullio

8 Sep 2009 11:56

London midday: Gold shines to push Footsie higher

Gold pushing through the $1,000 per ounce mark has helped Footsie post decent gains in the morning session with miners generally in demand again. Kazakhmys, Antofagasta, Rio Tinto, Anglo American, Xstrata, Randgold Resources and Vedanta Resources lead the mining sector higher. It is third time that

8 Sep 2009 08:50

Sector movers: Retail rises as Kingfisher takes off

Kingfisher, the company behind B&Q and Homebase, is lifting the retail sector after saying adjusted pre-tax profit for the six months to 1 August will be between £285m and £290m. DSG International, which owns the Currys and PC World chains, is also higher after appointing Tim How, former boss of Ma

8 Sep 2009 07:30

Abcam profits and dividend double

Catalogue-based antibodies distributor Abcam underlined the recession-proof nature of its business with doubled profits in the year just ended. The AIM-listed group made £16.3m in the year to June, against £8m last time, on revenues up by 55.2% to £56.8m (2008: £36.6m) and by 27.8% on a constant cu

7 Sep 2009 15:48

Tuesday preview: Market to digest fresh data

Investors will have some economic data to get their teeth into on Tuesday, with industrial production and manufacturing numbers for July due early on. Both reports are expected to reveal modest growth. Industrial production is forecast to have risen 0.2% during the month following June's 0.5% growt

Latest Share Chat

ABC.L Share News (ABC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abcam to acquire Boai NKY subsidiary BioVision for USD340 million

Login to your account

Quickpicks are a member only feature

Login to your account